ATE251173T1 - 4ß-SUBSTITUTIERTE-9-DEOXO-9A-AZA-9A- HOMOERYTHROMYCIN A DERIVATE - Google Patents

4ß-SUBSTITUTIERTE-9-DEOXO-9A-AZA-9A- HOMOERYTHROMYCIN A DERIVATE

Info

Publication number
ATE251173T1
ATE251173T1 AT98920693T AT98920693T ATE251173T1 AT E251173 T1 ATE251173 T1 AT E251173T1 AT 98920693 T AT98920693 T AT 98920693T AT 98920693 T AT98920693 T AT 98920693T AT E251173 T1 ATE251173 T1 AT E251173T1
Authority
AT
Austria
Prior art keywords
homoerythromycin
deoxo
aza
derivatives
substituted
Prior art date
Application number
AT98920693T
Other languages
German (de)
English (en)
Inventor
Brian Scott Bronk
Michael Anthony Letavic
Takushi Kaneko
Bingwei Vera Yang
Edward Alan Glazer
Hengmiao Cheng
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21959336&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE251173(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Application granted granted Critical
Publication of ATE251173T1 publication Critical patent/ATE251173T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT98920693T 1997-06-11 1998-05-29 4ß-SUBSTITUTIERTE-9-DEOXO-9A-AZA-9A- HOMOERYTHROMYCIN A DERIVATE ATE251173T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4934897P 1997-06-11 1997-06-11
PCT/IB1998/000839 WO1998056802A1 (en) 1997-06-11 1998-05-29 4'-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives

Publications (1)

Publication Number Publication Date
ATE251173T1 true ATE251173T1 (de) 2003-10-15

Family

ID=21959336

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98920693T ATE251173T1 (de) 1997-06-11 1998-05-29 4ß-SUBSTITUTIERTE-9-DEOXO-9A-AZA-9A- HOMOERYTHROMYCIN A DERIVATE

Country Status (50)

Country Link
US (4) US6420536B1 (US06559137-20030506-C00182.png)
EP (1) EP0988310B9 (US06559137-20030506-C00182.png)
JP (2) JP3315704B2 (US06559137-20030506-C00182.png)
KR (1) KR100396168B1 (US06559137-20030506-C00182.png)
CN (4) CN101691390A (US06559137-20030506-C00182.png)
AP (1) AP1231A (US06559137-20030506-C00182.png)
AR (1) AR013086A1 (US06559137-20030506-C00182.png)
AT (1) ATE251173T1 (US06559137-20030506-C00182.png)
AU (1) AU749816B2 (US06559137-20030506-C00182.png)
BG (1) BG64391B1 (US06559137-20030506-C00182.png)
BR (1) BRPI9810519B8 (US06559137-20030506-C00182.png)
CA (1) CA2293823C (US06559137-20030506-C00182.png)
CO (1) CO4950611A1 (US06559137-20030506-C00182.png)
CZ (1) CZ298556B6 (US06559137-20030506-C00182.png)
DE (2) DE122004000018I2 (US06559137-20030506-C00182.png)
DK (1) DK0988310T3 (US06559137-20030506-C00182.png)
DZ (1) DZ2514A1 (US06559137-20030506-C00182.png)
EA (1) EA002441B1 (US06559137-20030506-C00182.png)
EG (1) EG24081A (US06559137-20030506-C00182.png)
ES (1) ES2205487T3 (US06559137-20030506-C00182.png)
FR (1) FR04C0013I2 (US06559137-20030506-C00182.png)
GT (1) GT199800077A (US06559137-20030506-C00182.png)
HK (3) HK1028048A1 (US06559137-20030506-C00182.png)
HN (1) HN1998000086A (US06559137-20030506-C00182.png)
HR (1) HRP980314B1 (US06559137-20030506-C00182.png)
HU (2) HU228005B1 (US06559137-20030506-C00182.png)
ID (1) ID22992A (US06559137-20030506-C00182.png)
IL (1) IL132809A0 (US06559137-20030506-C00182.png)
IS (1) IS1998B (US06559137-20030506-C00182.png)
LU (1) LU91076I9 (US06559137-20030506-C00182.png)
MA (1) MA24564A1 (US06559137-20030506-C00182.png)
ME (1) ME00876B (US06559137-20030506-C00182.png)
MY (1) MY123354A (US06559137-20030506-C00182.png)
NL (1) NL300150I2 (US06559137-20030506-C00182.png)
NO (1) NO316911B1 (US06559137-20030506-C00182.png)
NZ (2) NZ500660A (US06559137-20030506-C00182.png)
OA (1) OA11224A (US06559137-20030506-C00182.png)
PA (1) PA8452201A1 (US06559137-20030506-C00182.png)
PE (1) PE79699A1 (US06559137-20030506-C00182.png)
PL (1) PL191601B1 (US06559137-20030506-C00182.png)
PT (1) PT988310E (US06559137-20030506-C00182.png)
RS (1) RS49675B (US06559137-20030506-C00182.png)
SI (1) SI0988310T1 (US06559137-20030506-C00182.png)
SK (1) SK284171B6 (US06559137-20030506-C00182.png)
TN (1) TNSN98082A1 (US06559137-20030506-C00182.png)
TW (1) TW472060B (US06559137-20030506-C00182.png)
UA (1) UA67744C2 (US06559137-20030506-C00182.png)
UY (1) UY25040A1 (US06559137-20030506-C00182.png)
WO (1) WO1998056802A1 (US06559137-20030506-C00182.png)
ZA (1) ZA985017B (US06559137-20030506-C00182.png)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN1998000086A (es) * 1997-06-11 1999-03-08 Pfizer Prod Inc Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.
WO1999012552A1 (en) * 1997-09-10 1999-03-18 Merck & Co., Inc. 9a-AZALIDES AS VETERINARY ANTIMICROBIAL AGENTS
EP1779853A3 (en) * 1997-09-10 2010-01-27 Merial Ltd. 9a-azalides as veterinary antimicrobial agents
US6339063B1 (en) 1997-09-10 2002-01-15 Merck & Co., Inc. 9a-azalides as veterinary antimicrobial agents
AP9801420A0 (en) * 1998-01-02 1998-12-31 Pfizer Prod Inc Novel macrolides.
EP1437360A3 (en) * 1998-08-19 2005-04-06 Pfizer Products Inc. C11 Carbamates of macrolide antibacterials
US6043227A (en) * 1998-08-19 2000-03-28 Pfizer Inc. C11 carbamates of macrolide antibacterials
US6100240A (en) * 1998-10-09 2000-08-08 Pfizer Inc Macrolide derivatives
CA2411293A1 (en) * 1999-01-28 2000-07-28 Pfizer Products Inc. Novel azalides and methods of making same
DK1189912T3 (da) * 1999-05-18 2008-06-30 Pfizer Prod Inc Nye krystallinske former af et makrolid antibiotikum
SK15162001A3 (sk) * 1999-05-24 2003-02-04 Pfizer Products Inc. Deriváty 13-metylerytromycínu
US6465437B1 (en) * 1999-06-30 2002-10-15 Pfizer Inc. Diphosphate salt of a 4″-substituted-9-deoxo-9A-AZA-9A- homoerythromycin derivative and its pharmaceutical composition
DE60025370T2 (de) * 1999-08-24 2006-09-21 Abbott Laboratories, Abbott Park 9a-azalide mit antibakterieller wirkung
US6764996B1 (en) 1999-08-24 2004-07-20 Abbott Laboratories 9a-azalides with antibacterial activity
US6608033B1 (en) 1999-08-27 2003-08-19 Pfizer Inc. Treatment or prevention of coccidiosis
PT1250343E (pt) * 2000-01-27 2003-11-28 Pfizer Prod Inc Composicoes de antibioticos de azalida
KR20030031479A (ko) * 2000-04-27 2003-04-21 화이자 프로덕츠 인코포레이티드 포유동물에서 세균 감염 또는 원생생물 감염을 치료 또는 예방하기 위한 아잘라이드 항생제 조성물
BR0209241A (pt) * 2001-04-27 2004-06-15 Pfizer Prod Inc Processo para preparação de derivados de9-deoxo-9a-aza-9a-homoeritromicina a 4-substituida
AU2002317415A1 (en) * 2001-08-01 2003-02-17 Pfizer Products Inc. Azalide antibiotic compositions
CA2529817C (en) 2003-03-10 2013-02-12 Optimer Pharmaceuticals, Inc. Novel antibacterial agents
US7276487B2 (en) 2003-09-23 2007-10-02 Enanta Pharmaceuticals, Inc. 9a, 11-3C-bicyclic 9a-azalide derivatives
CA2546195A1 (en) * 2003-11-21 2005-06-02 Pfizer Products Inc. The use of anti biotics as vaccine adjuvants
NZ550464A (en) * 2004-03-16 2010-10-29 Boehringer Ingelheim Int Glucopyranosyl-substituted benzol derivatives, drugs containing said compounds, the use thereof and method for the production thereof
US20060116336A1 (en) * 2004-03-17 2006-06-01 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
US7468428B2 (en) * 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
US7402568B2 (en) 2004-09-29 2008-07-22 Enanta Pharmaceuticals, Inc. Bicyclic 9a-azalide derivatives
US7767797B1 (en) * 2004-09-30 2010-08-03 Synovo Gmbh Macrocyclic compounds and methods of use thereof
US7271155B2 (en) 2005-01-07 2007-09-18 Enanta Pharmaceuticals, Inc. 9A, 11-2C-bicyclic 9a-azalide derivatives
US20080227730A1 (en) * 2005-01-14 2008-09-18 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. 9A-Carbamoyl and Thiocarbamoyl Azalides With Antimalarial Activity
JP5698979B2 (ja) * 2007-10-25 2015-04-08 センプラ ファーマシューティカルズ,インコーポレイテッド マクロライド系抗菌剤の調製プロセス
JP5602748B2 (ja) 2008-10-24 2014-10-08 センプラ ファーマシューティカルズ,インコーポレイテッド トリアゾール含有マクロライドを用いた生体防御
US9937194B1 (en) * 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
ES2608285T3 (es) 2009-09-10 2017-04-07 Cempra Pharmaceuticals, Inc. Procedimientos para el tratamiento de paludismo, tuberculosis y enfermedades por MAC
DK2550286T3 (en) 2010-03-22 2016-02-29 Cempra Pharmaceuticals Inc CRYSTALLINE FORMS OF A MACROLID AND APPLICATIONS THEREOF
BR112012029586A2 (pt) 2010-05-20 2016-08-02 Cempra Pharmaceuticals Inc processos para preparar macrolídeos e cetolídeos e intermediários dos mesmos
JP6042334B2 (ja) 2010-09-10 2016-12-14 センプラ ファーマシューティカルズ,インコーポレイテッド 疾患治療のための水素結合形成フルオロケトライド
ES2532455T3 (es) 2010-09-20 2015-03-27 Novartis Tiergesundheit Ag Nuevo procedimiento de preparación de 9-desoxo-9a-aza-9a-homoeritromicina modificada en el C-4'' del anillo de cladinosa por un grupo epóxido
CA2814333A1 (en) * 2010-10-10 2012-04-19 Synovo Gmbh Anti-inflammatory macrolides
CN102993250B (zh) * 2011-07-06 2016-02-10 洛阳惠中兽药有限公司 C-3取代的-9-脱氧-9a-氮杂-9a-高红霉素a衍生物
CN102260306B (zh) * 2011-07-22 2012-07-18 山东鲁抗舍里乐药业有限公司 一种制备泰拉霉素的方法
WO2013013834A1 (en) 2011-07-27 2013-01-31 Farma Grs, D.O.O. New crystalline forms of tulathromycin
US10188674B2 (en) 2012-03-27 2019-01-29 Cempra Pharmaceuticals, Inc. Parenteral formulations for administering macrolide antibiotics
CN102786569B (zh) * 2012-09-07 2016-12-07 安徽中升药业有限公司 泰拉霉素中间体及其制备方法与泰拉霉素的制备方法
JP6426696B2 (ja) 2013-03-14 2018-11-21 センプラ ファーマシューティカルズ,インコーポレイテッド 呼吸器疾患の治療のための方法および製剤
US9751908B2 (en) 2013-03-15 2017-09-05 Cempra Pharmaceuticals, Inc. Convergent processes for preparing macrolide antibacterial agents
SI3027634T1 (sl) * 2013-07-31 2018-10-30 Farma Grs, D.O.O. Proces za pripravo tulatromicina
CN103497227B (zh) * 2013-09-13 2015-09-30 青岛科技大学 一种泰拉菌素中间体的制备方法
CN104725446B (zh) * 2015-03-26 2017-10-27 宁夏泰瑞制药股份有限公司 一种从泰拉霉素粗品中分离泰拉霉素a和泰拉霉素b的方法
CN104861018A (zh) * 2015-06-17 2015-08-26 瑞普(天津)生物药业有限公司 一种泰拉菌素的制备方法
CN105646617A (zh) * 2016-01-21 2016-06-08 杭州海尔希畜牧科技有限公司 一种制备泰拉霉素的方法
FR3048612B1 (fr) * 2016-03-14 2020-10-02 Septeos Tulathromycine potentialisee
CN106046077B (zh) * 2016-08-04 2019-07-26 湖北美天生物科技股份有限公司 一种泰拉霉素a的合成方法
CN108003207B (zh) 2017-12-19 2019-05-10 海门慧聚药业有限公司 制备泰拉霉素的方法
CN111087433B (zh) * 2018-10-23 2023-03-21 湖北美天生物科技股份有限公司 一种泰拉霉素中间体的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI8110592A8 (en) * 1981-03-06 1996-06-30 Pliva Pharm & Chem Works Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof
US4474768A (en) * 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
US4512982A (en) * 1984-04-13 1985-04-23 Pfizer Inc. 9α-Aza-9α-homoerythromycin compounds, pharmaceutical composition and therapeutic method
CA2064634C (en) * 1991-04-04 1998-08-04 James V. Heck 9-deoxo-8a-aza-8a-homoerythromycin a derivatives modified at the 4"- and8a-positions
US5226958A (en) * 1991-04-11 1993-07-13 Pacemark, Inc. Sealant for pneumatic inner tubes and tubeless tires
EP0549040A1 (en) * 1991-12-20 1993-06-30 Merck & Co. Inc. Methods of making 4" derivatives of 9-deoxo-8a-aza-8a-alkyl-8a-homoerythromycin A
US5441939A (en) * 1994-03-04 1995-08-15 Pfizer Inc. 3"-desmethoxy derivatives of erythromycin and azithromycin
HN1998000086A (es) 1997-06-11 1999-03-08 Pfizer Prod Inc Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.
UA70972C2 (uk) 1998-11-20 2004-11-15 Пфайзер Продактс Інк. 13-членні азаліди і їх застосування як антибіотиків

Also Published As

Publication number Publication date
KR20010013632A (ko) 2001-02-26
DK0988310T3 (da) 2003-12-15
LU91076I9 (en) 2018-07-02
HRP980314A2 (en) 1999-04-30
DE122004000018I1 (de) 2004-09-30
NZ514871A (en) 2003-08-29
HK1028048A1 (en) 2001-02-02
EP0988310B1 (en) 2003-10-01
PA8452201A1 (es) 2000-05-24
ZA985017B (en) 1999-12-17
HUS1200028I1 (hu) 2016-08-29
US20040023896A1 (en) 2004-02-05
US20040180842A1 (en) 2004-09-16
PL337505A1 (en) 2000-08-28
SK168399A3 (en) 2000-11-07
UA67744C2 (uk) 2004-07-15
CA2293823A1 (en) 1998-12-17
NO996106D0 (no) 1999-12-10
EA199901015A1 (ru) 2000-06-26
YU58699A (US06559137-20030506-C00182.png) 2002-08-12
BRPI9810519B1 (pt) 2012-02-22
GT199800077A (es) 1999-12-02
AU7347598A (en) 1998-12-30
ID22992A (id) 1999-12-23
US6777393B2 (en) 2004-08-17
EP0988310B9 (en) 2006-03-08
BRPI9810519A (pt) 2000-09-19
IL132809A0 (en) 2001-03-19
DE69818665D1 (de) 2003-11-06
OA11224A (en) 2003-07-16
FR04C0013I1 (US06559137-20030506-C00182.png) 2004-06-11
AU749816B2 (en) 2002-07-04
JP2000514098A (ja) 2000-10-24
US6936592B2 (en) 2005-08-30
CN101691390A (zh) 2010-04-07
CN1243766C (zh) 2006-03-01
CN1172947C (zh) 2004-10-27
BG103945A (en) 2000-07-31
HUP0002209A2 (hu) 2000-12-28
JP3315704B2 (ja) 2002-08-19
CA2293823C (en) 2004-02-17
LU91076I2 (fr) 2004-07-05
HN1998000086A (es) 1999-03-08
HK1088014A1 (en) 2006-10-27
TNSN98082A1 (fr) 2005-03-15
KR100396168B1 (ko) 2003-08-27
SI0988310T1 (en) 2004-02-29
DE69818665T2 (de) 2004-04-29
CN1566129A (zh) 2005-01-19
PT988310E (pt) 2003-12-31
NO316911B1 (no) 2004-06-21
CZ298556B6 (cs) 2007-11-07
AP9801255A0 (en) 1998-06-30
DZ2514A1 (fr) 2003-02-01
HRP980314B1 (en) 2004-04-30
BG64391B1 (bg) 2004-12-30
EA002441B1 (ru) 2002-04-25
ME00876B (me) 2012-06-20
RS49675B (sr) 2007-11-15
IS5252A (is) 1999-11-16
AR013086A1 (es) 2000-12-13
US6420536B1 (en) 2002-07-16
CN1259136A (zh) 2000-07-05
AP1231A (en) 2003-12-11
TW472060B (en) 2002-01-11
CO4950611A1 (es) 2000-09-01
UY25040A1 (es) 2000-09-29
US20020061858A1 (en) 2002-05-23
HUP0002209A3 (en) 2003-05-28
IS1998B (is) 2005-03-15
JP2002316933A (ja) 2002-10-31
DE122004000018I2 (de) 2011-01-13
NL300150I1 (nl) 2004-08-02
CN1793155B (zh) 2010-05-12
MY123354A (en) 2006-05-31
WO1998056802A1 (en) 1998-12-17
BRPI9810519B8 (pt) 2022-11-16
EP0988310A1 (en) 2000-03-29
SK284171B6 (sk) 2004-10-05
PE79699A1 (es) 1999-08-25
MA24564A1 (fr) 1998-12-31
CN1793155A (zh) 2006-06-28
HU228005B1 (en) 2012-08-28
EG24081A (en) 2008-05-11
NO996106L (no) 2000-02-10
FR04C0013I2 (US06559137-20030506-C00182.png) 2005-10-21
NZ500660A (en) 2002-03-01
CZ442199A3 (cs) 2000-07-12
ES2205487T3 (es) 2004-05-01
NL300150I2 (nl) 2004-09-01
HK1068893A1 (en) 2005-07-29
PL191601B1 (pl) 2006-06-30

Similar Documents

Publication Publication Date Title
ATE251173T1 (de) 4ß-SUBSTITUTIERTE-9-DEOXO-9A-AZA-9A- HOMOERYTHROMYCIN A DERIVATE
ATE260243T1 (de) N-aroylphenylalaninderivate
ATE235220T1 (de) Resorcinderivate
ID22781A (id) Turunan-turunan nikotinamida
DE69817186D1 (de) Diaminorhodamin-derivate
DE69706292D1 (de) Chinazoline derivate
DE69613368D1 (de) Chinazolin derivate
DE69613369D1 (de) Chinazolin derivate
DE69613367D1 (de) Chinazolin derivate
DE69807508D1 (de) Positionsbestimmung
PT915088E (pt) Derivados de d-prolina
ATE255098T1 (de) Substituierte chromanderivate
PT1003719E (pt) Derivados microbicidas de n-sulfonil-glicinalquiniloxifenemetilamida
PT1027362E (pt) Derivados de cetolidos 2-halogeno-6-o-substituidos
ATE277917T1 (de) Alkylaminobenzothiazole und -benzoxazole derivate
ATE440854T1 (de) 5-deoxy-cytidin-derivate
ATE255099T1 (de) Substituierte chromanderivate
DE69904738D1 (de) 2-phenylpyran-4-one derivate
DE69829682D1 (de) Cis-disubstituierte aminocycloalkyl-pyrrolidin-derivate
DE69913333D1 (de) Hygromycin a derivate
DE69828780D1 (de) Amidinocamptpthecin-derivate
NO981495L (no) Fenoksymetylpiperidin-derivater
DE69805974D1 (de) 5-aroylnaphthalin derivate
ATE292143T1 (de) Angiotensinderivate
DE59812470D1 (de) Positioniertisch